Departments
What we are doing:
![550×500 550x500](https://ptc-anticancer.co.uk/wp-content/uploads/2023/01/550x500.png)
PTC's laboratories have three main departments:
Anti-cancer Drug Formulation Department
![](https://ptc-anticancer.co.uk/wp-content/uploads/2023/01/1-14.png)
![](https://ptc-anticancer.co.uk/wp-content/uploads/2023/01/Untitled-design-88.jpg)
Anti-cancer Drug Analysis Department
PTC's Analysis Areas:
- Analytical and Bioanalytical method development and validation
- QbD-based analytical method optimization
- Impurity Profiling
- Development and validation of stability indicating analytical methods
- Development and evaluation of anti-cancer drugs/ formulations for heavy metal toxicity.
Anti-cancer drugs Stability Study Department
A stability study is a vital stake in the anti-cancer drug development process. Stability is the only way that assures whether the anti-cancer drug is within acceptance criteria or not. Stability comes into focus when the quality and efficiency of the anti-cancer drug are concerned.
PTC ‘s stability study department provides the necessary data for the shipping and distribution of anti-cancer drug products. In this department, three ensured stabilities are studied which are physical, chemical, and microbiological.
In PTC, a stability study is performed at various stages of the anti-cancer drug development process. At the early stage of drug development, accelerated stability studies are performed to find out the rate of degradation of the product if stored for a longer period under specific conditions. After that, a forced degradation study is carried out to check the effect of stressed external conditions on the drug product.
![](https://ptc-anticancer.co.uk/wp-content/uploads/2023/01/3-12.png)
In our PTC's stability department, we are mainly concerned with the following types of stability studies:
- Long-term stability
- Intermediate stability
- Accelerated stability
- In-use stability